213 related articles for article (PubMed ID: 19116988)
1. Identification of extracellular delta-catenin accumulation for prostate cancer detection.
Lu Q; Zhang J; Allison R; Gay H; Yang WX; Bhowmick NA; Frelix G; Shappell S; Chen YH
Prostate; 2009 Mar; 69(4):411-8. PubMed ID: 19116988
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of delta-catenin/neural plakophilin-related armadillo protein is associated with the down-regulation and redistribution of E-cadherin and p120ctn in human prostate cancer.
Lu Q; Dobbs LJ; Gregory CW; Lanford GW; Revelo MP; Shappell S; Chen YH
Hum Pathol; 2005 Oct; 36(10):1037-48. PubMed ID: 16226102
[TBL] [Abstract][Full Text] [Related]
3. N-Cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion withStromal cells.
Tran NL; Nagle RB; Cress AE; Heimark RL
Am J Pathol; 1999 Sep; 155(3):787-98. PubMed ID: 10487836
[TBL] [Abstract][Full Text] [Related]
4. delta-Catenin promotes prostate cancer cell growth and progression by altering cell cycle and survival gene profiles.
Zeng Y; Abdallah A; Lu JP; Wang T; Chen YH; Terrian DM; Kim K; Lu Q
Mol Cancer; 2009 Mar; 8():19. PubMed ID: 19284555
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas.
Kallakury BV; Sheehan CE; Winn-Deen E; Oliver J; Fisher HA; Kaufman RP; Ross JS
Cancer; 2001 Dec; 92(11):2786-95. PubMed ID: 11753952
[TBL] [Abstract][Full Text] [Related]
6. Leupaxin acts as a mediator in prostate carcinoma progression through deregulation of p120catenin expression.
Kaulfuss S; von Hardenberg S; Schweyer S; Herr AM; Laccone F; Wolf S; Burfeind P
Oncogene; 2009 Nov; 28(45):3971-82. PubMed ID: 19701244
[TBL] [Abstract][Full Text] [Related]
7. Co-downregulation of cell adhesion proteins alpha- and beta-catenins, p120CTN, E-cadherin, and CD44 in prostatic adenocarcinomas.
Kallakury BV; Sheehan CE; Ross JS
Hum Pathol; 2001 Aug; 32(8):849-55. PubMed ID: 11521230
[TBL] [Abstract][Full Text] [Related]
8. Caveolin-1 and MAL are located on prostasomes secreted by the prostate cancer PC-3 cell line.
Llorente A; de Marco MC; Alonso MA
J Cell Sci; 2004 Oct; 117(Pt 22):5343-51. PubMed ID: 15466889
[TBL] [Abstract][Full Text] [Related]
9. Identification of E2F1 as a positive transcriptional regulator for delta-catenin.
Kim K; Oh M; Ki H; Wang T; Bareiss S; Fini ME; Li D; Lu Q
Biochem Biophys Res Commun; 2008 May; 369(2):414-20. PubMed ID: 18302937
[TBL] [Abstract][Full Text] [Related]
10. Expression analysis of delta-catenin and prostate-specific membrane antigen: their potential as diagnostic markers for prostate cancer.
Burger MJ; Tebay MA; Keith PA; Samaratunga HM; Clements J; Lavin MF; Gardiner RA
Int J Cancer; 2002 Jul; 100(2):228-37. PubMed ID: 12115574
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of δ-catenin palmitoylation slows the progression of prostate cancer.
Wang B; Zhou R; Wu J; Kim H; Kim K
Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119741. PubMed ID: 38697304
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of E-cadherin and the cadherin-associated molecules alpha-, beta-, gamma-catenin and p120ctn in prostate cancer specific survival: a long-term follow-up study.
van Oort IM; Tomita K; van Bokhoven A; Bussemakers MJ; Kiemeney LA; Karthaus HF; Witjes JA; Schalken JA
Prostate; 2007 Sep; 67(13):1432-8. PubMed ID: 17639504
[TBL] [Abstract][Full Text] [Related]
13. δ-Catenin, a Wnt/β-catenin modulator, reveals inducible mutagenesis promoting cancer cell survival adaptation and metabolic reprogramming.
Nopparat J; Zhang J; Lu JP; Chen YH; Zheng D; Neufer PD; Fan JM; Hong H; Boykin C; Lu Q
Oncogene; 2015 Mar; 34(12):1542-52. PubMed ID: 24727894
[TBL] [Abstract][Full Text] [Related]
14. Increased nucleotide polymorphic changes in the 5'-untranslated region of delta-catenin (CTNND2) gene in prostate cancer.
Wang T; Chen YH; Hong H; Zeng Y; Zhang J; Lu JP; Jeansonne B; Lu Q
Oncogene; 2009 Jan; 28(4):555-64. PubMed ID: 18978817
[TBL] [Abstract][Full Text] [Related]
15. δ-Catenin Participates in EGF/AKT/p21
Shen Y; Lee HJ; Zhou R; Kim H; Chen G; Cho YC; Kim K
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069970
[TBL] [Abstract][Full Text] [Related]
16. Intratumor δ-catenin heterogeneity driven by genomic rearrangement dictates growth factor dependent prostate cancer progression.
Li M; Nopparat J; Aguilar BJ; Chen YH; Zhang J; Du J; Ai X; Luo Y; Jiang Y; Boykin C; Lu Q
Oncogene; 2020 May; 39(22):4358-4374. PubMed ID: 32313227
[TBL] [Abstract][Full Text] [Related]
17. Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression.
Ayala G; Morello M; Frolov A; You S; Li R; Rosati F; Bartolucci G; Danza G; Adam RM; Thompson TC; Lisanti MP; Freeman MR; Vizio DD
J Pathol; 2013 Sep; 231(1):77-87. PubMed ID: 23729330
[TBL] [Abstract][Full Text] [Related]
18. Dual roles of E-cadherin in prostate cancer invasion.
Chunthapong J; Seftor EA; Khalkhali-Ellis Z; Seftor RE; Amir S; Lubaroff DM; Heidger PM; Hendrix MJ
J Cell Biochem; 2004 Mar; 91(4):649-61. PubMed ID: 14991757
[TBL] [Abstract][Full Text] [Related]
19. Human homolog of Drosophila Hairy and enhancer of split 1, Hes1, negatively regulates δ-catenin (CTNND2) expression in cooperation with E2F1 in prostate cancer.
Lu JP; Zhang J; Kim K; Case TC; Matusik RJ; Chen YH; Wolfe M; Nopparat J; Lu Q
Mol Cancer; 2010 Nov; 9():304. PubMed ID: 21106062
[TBL] [Abstract][Full Text] [Related]
20. Transcription expression and clinical significance of dishevelled-3 mRNA and δ-catenin mRNA in pleural effusions from patients with lung cancer.
Li XY; Liu SL; Cha N; Zhao YJ; Wang SC; Li WN; Wang EH; Wu GP
Clin Dev Immunol; 2012; 2012():904946. PubMed ID: 22461838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
